MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Phone615-627-4710
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$57.26 million
Profitability
Miscellaneous
Employees11
Next Earnings Date3/27/2019 (Estimated)
OptionableNot Optionable
MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions
What is MedEquities Realty Trust's stock symbol?
MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."
How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?
MedEquities Realty Trust announced a dividend on Wednesday, January 2nd. Shareholders of record on Monday, March 11th will be given a dividend of $0.21 per share on Friday, March 8th. The ex-dividend date of this dividend is Friday, March 8th. View MedEquities Realty Trust's Dividend History.
How were MedEquities Realty Trust's earnings last quarter?
MedEquities Realty Trust Inc (NYSE:MRT) announced its earnings results on Wednesday, August, 8th. The financial services provider reported $0.10 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.30 by $0.20. The financial services provider earned $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a return on equity of 1.88% and a net margin of 9.89%. View MedEquities Realty Trust's Earnings History.
When is MedEquities Realty Trust's next earnings date?
What price target have analysts set for MRT?
9 Wall Street analysts have issued 1 year price objectives for MedEquities Realty Trust's stock. Their predictions range from $9.00 to $12.00. On average, they expect MedEquities Realty Trust's share price to reach $10.6250 in the next twelve months. This suggests that the stock has a possible downside of 1.8%. View Analyst Price Targets for MedEquities Realty Trust.
What is the consensus analysts' recommendation for MedEquities Realty Trust?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust.
Has MedEquities Realty Trust been receiving favorable news coverage?
Media headlines about MRT stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. MedEquities Realty Trust earned a news impact score of -1.1 on InfoTrie's scale. They also gave media stories about the financial services provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of MedEquities Realty Trust's key competitors?
Some companies that are related to MedEquities Realty Trust include TIER REIT (TIER), TPG RE Finance Trust (TRTX), Kite Realty Group Trust (KRG), Industrial Logistics Properties Trust (ILPT), Monmouth R.E. Inv. (MNR), KKR Real Estate Finance Trust (KREF), ARMOUR Residential REIT (ARR), Summit Hotel Properties (INN), American Finance Trust (AFIN), Saul Centers (BFS), NY MTG TR INC/SH (NYMT), Interrent Real Estate Investment Trust (IIPZF), ARBOR RLTY TR I/SH (ABR), Easterly Government Properties (DEA) and Washington Prime Group (WPG).
What other stocks do shareholders of MedEquities Realty Trust own?
Who are MedEquities Realty Trust's key executives?
MedEquities Realty Trust's management team includes the folowing people:
- Mr. John W. McRoberts, Chairman & CEO (Age 66)
- Mr. William C. Harlan, Pres, COO & Director (Age 67)
- Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 49)
- Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 44)
- Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC
When did MedEquities Realty Trust IPO?
(MRT) raised $259 million in an IPO on Thursday, September 29th 2016. The company issued 19,900,000 shares at a price of $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.
Who are MedEquities Realty Trust's major shareholders?
MedEquities Realty Trust's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Prudential Financial Inc. (8.17%), American Century Companies Inc. (6.95%), BlackRock Inc. (5.54%), Nuveen Asset Management LLC (3.88%), Bank of New York Mellon Corp (1.31%) and Geode Capital Management LLC (1.07%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust.
Which institutional investors are selling MedEquities Realty Trust stock?
MRT stock was sold by a variety of institutional investors in the last quarter, including Martingale Asset Management L P, Nuveen Asset Management LLC, American Century Companies Inc., Bank of New York Mellon Corp, LSV Asset Management, Raymond James & Associates, Bessemer Group Inc. and Janney Montgomery Scott LLC. View Insider Buying and Selling for MedEquities Realty Trust.
Which institutional investors are buying MedEquities Realty Trust stock?
MRT stock was acquired by a variety of institutional investors in the last quarter, including Prudential Financial Inc., D. E. Shaw & Co. Inc., BlackRock Inc., Raymond James Financial Services Advisors Inc., Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Two Sigma Investments LP and Geode Capital Management LLC. Company insiders that have bought MedEquities Realty Trust stock in the last two years include John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust.
How do I buy shares of MedEquities Realty Trust?
Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MedEquities Realty Trust's stock price today?
One share of MRT stock can currently be purchased for approximately $10.82.
How big of a company is MedEquities Realty Trust?
MedEquities Realty Trust has a market capitalization of $344.51 million and generates $57.26 million in revenue each year. The financial services provider earns $5.66 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 11 workers across the globe.
What is MedEquities Realty Trust's official website?
How can I contact MedEquities Realty Trust?
MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]
MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
